This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Synaptic transmission in the CNS represents the classic mechanism through which neural cells communicate. While vesicular neurotransmitter release has been known to be the preserve of gray matter, it is now known that synaptic-style release of glutamate, the brain's major excitatory neurotransmitter, occurs deep in white matter. Here it permits communication between axons and glial cells, enabling axon activity to couple with high fidelity to glial physiology. As white matter is increasingly well-recognized as a substrate for disease, dysregulation of white matter synaptic transmission will play an important role in the development of pathologies as diverse as stroke, multiple sclerosis, Alzheimer disease, and schizophrenia. This review highlights progress in this new and important field.
Footnotes
References e1–e25 are available on the Neurology® Web site at www.neurology.org.
Supplemental data at www.neurology.org
-
- AD
- Alzheimer disease
- AMPAR
- α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor
- EAE
- experimental autoimmune encephalomyelitis
- GM
- gray matter
- H/I
- hypoxic-ischemic
- HD
- Huntington disease
- iGluR
- ionotropic glutamate receptor
- MR-DTI
- magnetic resonance diffusion tensor imaging
- MS
- multiple sclerosis
- NMDAR
- NMDA receptor
- OPC
- oligodendrocyte precursor cell
- PVL
- periventricular leukomalacia
- RON
- rat optic nerve
- VGCC
- voltage-gated Ca2+ channel
- WM
- white matter
- Received May 21, 2010.
- Accepted September 20, 2010.
- Copyright © 2011 by AAN Enterprises, Inc.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan